Menu

News

Subscribe to our newsletter to learn in depth about our areas of expertise


Laboratorio científico con elementos visuales que representan la elección entre configuraciones RUO, Medical Device e IVD.

Biomedicine

RUO, Medical Device or IVD? How to Choose the Right Configuration for Your Laboratory

Key considerations when choosing between RUO, Medical Device and IVD solutions based on intended use and laboratory requirements. Choosing laboratory equipment is not only about technical performance. Intended use, the working environment and regulatory requirements are also essential when selecting the right configuration. Not Every Laboratory Needs the Same Solution Choosing between RUO, Medical Device …

More info

Ion Torrent Genexus for automated NGS in oncology

Biomedicine

Automated NGS in Oncology with Ion Torrent Genexus

Automated NGS in oncology to accelerate genomic analysis, reduce hands-on time and deliver faster results with Ion Torrent Genexus. Precision medicine requires fast, reliable and actionable results. In this context, automated NGS in oncology has become a key tool for accelerating genomic analysis and supporting decision-making in the laboratory. The Ion Torrent Genexus system is …

More info

Equipo Covaris Biomol en Torre Sevilla

Corporate

Growing where science moves forward

Biomol’s growth in Spain and Portugal is not driven solely by the opening of new markets or the achievement of strategic agreements. Above all, it is built through an active presence, trusted relationships and a way of working that places proximity at the heart of every project. June offered a particularly meaningful expression of this …

More info

VCN quantification by dPCR in CAR-T therapies.

Biomedicine

Vector Copy Number Quantification by dPCR: A Critical Parameter in CAR-T Therapies

A precise and reproducible technology to assess safety, efficacy and quality in CAR-T products and advanced therapies. Vector Copy Number quantification by dPCR has become a key analytical tool in the development, characterization and quality control of CAR-T therapies. This parameter measures the average number of integrated vector copies per cell. Therefore, it provides essential …

More info

XX SEFIN Congress Poster

Congresses

Biomol and Fundación Instituto Biomol participate in the XX SEFIN Congress 2026

Biomol took part as a sponsor in the XX SEFIN Congress 2026. This scientific meeting focused on biological nitrogen fixation and beneficial interactions between plants and microorganisms. In addition, Fundación Instituto Biomol awarded three grants to support the attendance of young researchers. Last May, the XX SEFIN Congress 2026 was held in Cádiz. The event …

More info

Liquid biopsy in oncohematology and pathology

Biopsy

Liquid biopsy in oncohematology and pathology: diagnostic integration in precision medicine

An integrated approach to improving molecular characterization, disease monitoring and clinical decision-making in oncology. Precision medicine has transformed the approach to cancer. It promotes the use of increasingly sensitive molecular tools to characterize disease, monitor progression and support clinical decision-making. In this context, the integration of liquid biopsy, pathology and oncohematology represents a key advance. …

More info

Cartel corporativo Biomol

Cámara de Comercio

Biomol April 2026: activity review, scientific congresses and business positioning

April was a highly active period for Biomol. In this Biomol April 2026 activity review, we look back at the main corporate, scientific and business milestones that strengthened the company’s presence in the biomedical sector. On one hand, Biomol took part in leading national congresses. On the other hand, the company reinforced its relationship with …

More info

CTCs

Biomedicine

CTCs and liquid biopsy: key technology for precision oncology

Liquid biopsy has become a key tool in translational oncology. While cfDNA analysis is already widely used, circulating tumor cells (CTCs) provide a more complex and informative sample. These cells are intact and viable, allowing real-time genomic, transcriptomic, proteomic, and functional analysis. However, their low frequency in peripheral blood (1–10 cells per mL) remains a …

More info

Equipo Biomol

Corporate

Biomol participates in the artificial intelligence event organized by Loyola University and the Sevilla FC Business Club

Biomol participated in the event “Applied AI: Strategy and Results”, organized by Loyola University Andalucía and the Sevilla FC Business Club, a meeting focused on analyzing how artificial intelligence applied to business is transforming corporate strategy, innovation and decision-making in organizations. Held at the Loyola University campus in Seville, the event brought together professionals, companies …

More info

Biomedicine

Ion Torrent Technology with S5 + Ion Chef: Fast, Flexible and Accessible NGS

Semiconductor-based NGS sequencing At Biomol, we work to make next-generation sequencing (NGS) easier to implement and simpler to scale. Ion Torrent technology is based on direct detection using a semiconductor chip, resulting in an agile, robust workflow that is particularly practical for research and clinical research laboratories. Ion Torrent performs sequencing by detecting the pH …

More info